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T
hat type 1 diabetes in humans and in animal
models represents a complex genetic disease is
universally accepted. Genetic dissection of type
1 diabetes in humans has typically entailed the
collection of large numbers of individuals scored on the
basis of the presence or absence of clinical disease (case/
control subjects). Statistically signiﬁcant differences in
allele frequencies distinguishing the affected subjects from
control subjects are used to demonstrate associations.
Human major histocompatibility complex (MHC) alleles,
primarily but not exclusively within the class II sets of
genes, are estimated to contribute up to 50% of genetic
risk. Because of the strength of the MHC contribution and
the genetic heterogeneity extant in humans, identiﬁcation of
non-MHC susceptibility loci by genome-wide association has
required the accumulation of large numbers of case/control
populations. Recent studies have identiﬁed up to 10 of such
non-MHC susceptibility regions under conditions where mul-
tiple HLA haplotypes are segregating (1).
In the NOD mouse, the paramount role of the MHC was
conﬁrmed by the ﬁnding that almost all diabetic mice
generated by outcross with diabetes-resistant strains were
homozygous for the NOD’s susceptibility-conferring H2
g7
MHC haplotype. Because inbred strains were used, linkage
was ascertained by treating type 1 diabetes as a dichoto-
mous trait, with diabetes susceptibility (Idd) genes iden-
tiﬁed by signiﬁcant deviations from expected Mendelian
ratios in the diabetic segregants. Initial segregation analy-
ses in crosses in which H2
g7 was also segregating only
suggested effects of several non-MHC Idd genes. However,
the true polygenic nature of type 1 diabetes in this model
followed the generation of outcross partner strains con-
genic for NOD’s susceptibility-conferring H2
g7, such that
only the non-MHC susceptibility modiﬁers segregated in a
cross (2,3). By now, over 30 non-MHC murine loci have
been identiﬁed, some of which (e.g., Ctla4, Il2) represent
likely orthologs for certain human non-MHC loci identiﬁed
by genome-wide association (4). Because extensive
genomic sequence information is available for NOD and
outcross partner strains, geneticists can subdivide loci
identiﬁed by linkage analysis across a broader genetic
region and use high-density single nucleotide polymor-
phisms and polymorphic microsatellite markers to facili-
tate ﬁne-mapping and candidate gene analysis.
Where does the rat ﬁgure into our understanding of type
1 diabetes genetic susceptibility? Consistent with the
pivotal contributions of MHC in humans and NOD mice,
only rat strains expressing RT1
u MHC class II alleles on
chromosome 20 are susceptible to the development of
spontaneous diabetes. The most widely distributed (and
thus most studied) are Biobreeding (BB) rats, a Wistar
Furth–related strain (5). The DP-BB (spontaneous diabe-
tes prone) substrain carries a recessive mutation on chro-
mosome 4 (Gimap5 [GTPase, IMAP family member 5])
producing severe peripheral T-lymphopenia, a phenotype
not found in at-risk humans or NOD mice. The nonlym-
phopenic DR-BB (spontaneous diabetes resistant) strain
carries a wild-type Gimap5 allele and does not develop
type 1 diabetes when protected by virus antibody–free
high-barrier facilities (5). However, type 1 diabetes can be
induced by an antibody that depletes naïve and regulatory
T-cells combined with either poly I:C treatment to simu-
late a virus infection or by infection with a rat parvovirus
(5). This inducible DR-BB model stands in sharp contrast
to the NOD mouse model, in which such immunostimula-
tory challenge typically prevents rather than induces type
1 diabetes. In addition to the two BB rat models, sponta-
neous type 1 diabetes also develops in three other non-
lymphopenic rat strains: the Komeda Diabetes Prone
(KDP) rat, the LEW.1AR1 rat, and the LEW.1WR1 rat (6,7).
In all of these strains, segregation analyses following
outcross to type 1 diabetes–resistant strains indicated
oligogenic rather than polygenic control, seemingly distin-
guishing these rat models from both at-risk humans and
the NOD mice in terms of genetic complexity.
This conclusion, based upon these earlier studies, can
now be rejected. In this issue of Diabetes, Wallis et al. (8)
have adopted the tactic used in NOD genetic analyses of
“preconditioning” the genome of the resistant strain, in
this case, the ACI rat. Before outcross to DP-BB rats, a
stock of ACI rats doubly congenic for the BB rat RT1
u
locus (Iddm1) and the T-lymphopenia–inducing mutation
in the Gimap5 gene (Iddm2) had been generated. The
hypothesis was that segregation of resistance alleles at
either of these two loci masked contributions from weaker
polygenes. This bicongenic stock remained type 1 diabetes
free, demonstrating the presence of additional Iddm al-
leles conferring resistance (9). However, F1 hybrids exhib-
ited a 21% incidence of type 1 diabetes by 180 days
(compared with a control DP-BB incidence of 84% by 76
days), showing the introduction of additional additive or
dominant alleles from the BB genome. Indeed, without
ﬁxing susceptibility at Iddm1 and Iddm2, an F1 incidence
of zero would have been likely. Given the high incidence in
F1, the authors generated 574 F2 rats, 19% of which
became diabetic. A ﬁrst-pass screen for linkage to the
dichotomous (qualitative) trait of clinical diabetes was
done using 224 polymorphic microsatellite markers. For
those markers producing a log10 likelihood ratio (LOD)
score 1, a follow-up analysis of the whole cohort (dia-
betics and nondiabetics) was performed to conﬁrm type 1
diabetes speciﬁcity of the linkage. Additional genetic in-
formation was gained by statistical analysis of scores for
three semiquantitative traits. Two (extent of cellular inﬁl-
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796 DIABETES, VOL. 58, APRIL 2009tration and degree of islet integrity) were phenotypes
allowing identiﬁcation of quantitative trait loci that control
insulitis developing in many nondiabetic rats as well as
diabetic probands. The third, age of type 1 diabetes onset,
allowed identiﬁcation of quantitative trait loci contributing
to the rate at which insulitis-mediated -cell destruction
developed.
The results of the study by Wallis et al. (8) leave little
doubt that the complexity of type 1 diabetes development
in the lymphopenic BB rat model is no less than that of
NOD mice or at-risk humans. For the multiple traits
analyzed, 12 Iddm loci (designated Iddm25-Iddm36) were
indicated: seven with signiﬁcant LOD scores and ﬁve with
suggestive scores. Interestingly, with the contributions of
Iddm1 and Iddm2 factored in, the authors estimated that
the newly identiﬁed linkages could account for not more
than 40% of the phenotypic variance. Thus, even more loci,
each with small effects (3% of the variance or less), are
likely contributing. Further, existence of strain-unique
combinations of these non-MHC Iddm genes is indicated
by reports of different linkages in the initial KDP and
LEW.1.AR1 analyses. The Wallis et al. linkages show
regions of synteny with known NOD Idd and human type
1 diabetes linkages. There are some notable overlays, such
as with the Il2 gene in NOD mice and the PTPN22 gene in
humans. What Wallis et al. clearly demonstrate is that
geneticists now have the tools for robust genome-wide
analysis for complex traits in the rat. The rat models of
type 1 diabetes have not previously received attention
comparable with that given to the NOD mouse. Although
the immune mechanisms underlying type 1 diabetes devel-
opment in the mouse and rat are similar in broad terms,
the precise pathways underlying the immune dysregula-
tion are strain dependent, as reﬂected by the KDP rat with
a Cblb mutation not common to the other rat models (7).
Those rat models in which viral triggering of type 1
diabetes by action on the immune system rather than
directly on the pancreatic -cells deserve much more
attention than they are currently receiving. In such an
environmentally triggered type 1 diabetes model, it will be
of great interest to see how many of the loci identiﬁed by
Wallis et al. for development of spontaneous type 1
diabetes will be identiﬁed and how many new ones will
emerge. Collectively, the combined results from mouse
and rat genetics show that studies in humans have many
more non-MHC loci yet to uncover beyond the 10 now
conﬁrmed.
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